RANDAL J KIRK Insider Trading $OGEN ORAGENICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

RANDAL J KIRK in ORAGENICS INC

Trading Symbol: OGEN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 14,481,089 shares
Current Value: $11,005,628
Latest Transaction: Jul 05 2016
$OGEN Market Capitalization: $38.33M
$OGEN Previous Close: $0.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RANDAL J KIRK in ORAGENICS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 05 2016OGENORAGENICS INCKIRK RANDAL J10% OwnerBuyP0.522,261,4191,166,66614,481,08912.2 M to 14.5 M (+18.51 %)
Dec 03 2015OGENORAGENICS INCKIRK RANDAL J10% OwnerBuyC1.503,381,0045,071,50612,219,6708.8 M to 12.2 M (+38.25 %)

Page:   1